Technology

Apple and OpenEvidence launch AI health chatbot study

Apple and OpenEvidence have launched a study at the HLTH conference to investigate how consumers interact with conversational health AI chatbots.

Apple and OpenEvidence launch AI health chatbot study

Experimental AI health study

Apple and OpenEvidence launched a study on Sunday at the HLTH conference in Las Vegas involving an experimental artificial intelligence-powered health chat application. This study focuses on how consumers interact with conversational health AI chatbots. Sumbul Desai, Apple’s vice president of health and fitness, said the company’s commitment to scientific rigor motivated the research into the application. The study aims to better understand what builds user trust, how people comprehend responses, and the quality of responses. Because Apple wanted to work with a partner that is clinically grounded, the company chose to work with OpenEvidence for this experimental application, which hints at possible new directions for both companies.

Brand combinations for health consumers

Daniel Nadler, the CEO of OpenEvidence, said OpenEvidence is the most trusted and loved brand product among doctors. He noted that Apple is the most trusted and loved brand and product among consumers, and especially health consumers. "So you have to bring these two things together. It’s like peanut butter and jelly," Nadler said during the partnership announcement on stage at the HLTH conference in Las Vegas. This collaboration combines the clinical grounding of OpenEvidence with the consumer reach of Apple. The research aims to study the quality of responses and how people comprehend them. The study also investigates what builds user trust when people interact with conversational health AI chatbots. The project explores how consumers interact with conversational health AI chatbots to improve the quality of the technology.